NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 212 filers reported holding NOVAVAX INC in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | – | 200 | +100.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 100 | -86.6% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 745 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -99.7% | 745 | -99.0% | 0.00% | -100.0% |
| Q2 2022 | $3,822,000 | -39.1% | 74,329 | -12.8% | 0.00% | -33.3% |
| Q1 2022 | $6,280,000 | -63.7% | 85,278 | -29.5% | 0.01% | -64.7% |
| Q4 2021 | $17,299,000 | +23.5% | 120,917 | +86.2% | 0.02% | +30.8% |
| Q3 2021 | $14,011,000 | +0.2% | 64,940 | -1.4% | 0.01% | -7.1% |
| Q2 2021 | $13,984,000 | +177.0% | 65,867 | +136.5% | 0.01% | +55.6% |
| Q1 2021 | $5,049,000 | +18.2% | 27,851 | -27.3% | 0.01% | +50.0% |
| Q4 2020 | $4,271,000 | +30.5% | 38,302 | +26.8% | 0.01% | +50.0% |
| Q3 2020 | $3,272,000 | +5177.4% | 30,200 | +555.1% | 0.00% | – |
| Q1 2020 | $62,000 | – | 4,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |